DNAPrint Genomics, Inc. (DNAG)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (1,900.00%)
Apr 30, 2025, 4:00 PM EDT
DNAPrint Genomics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2002 | 1998 - 2001 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '07 Sep 30, 2007 | Dec '06 Dec 31, 2006 | Dec '05 Dec 31, 2005 | Dec '04 Dec 31, 2004 | Dec '03 Dec 31, 2003 | Dec '02 Dec 31, 2002 | 1998 - 2001 |
| Revenue | 1.93 | 2.43 | 1.28 | 0.79 | 0.71 | 0.18 | Upgrade
|
| Revenue Growth (YoY) | -15.16% | 90.75% | 62.35% | 10.71% | 284.52% | 1182.58% | Upgrade
|
| Cost of Revenue | 1.48 | 1.68 | 0.95 | 0.51 | 0.43 | 0.07 | Upgrade
|
| Gross Profit | 0.45 | 0.75 | 0.33 | 0.28 | 0.28 | 0.11 | Upgrade
|
| Selling, General & Admin | 2.22 | 3.19 | 2.86 | 2.05 | 3.86 | 0.53 | Upgrade
|
| Research & Development | 4.53 | 6.43 | 2.12 | 1.56 | 2.65 | 2.2 | Upgrade
|
| Operating Expenses | 6.75 | 9.62 | 4.99 | 3.61 | 6.51 | 2.72 | Upgrade
|
| Operating Income | -6.31 | -8.87 | -4.66 | -3.33 | -6.23 | -2.61 | Upgrade
|
| Interest Expense | -1.51 | -2.88 | -2.34 | -0.08 | -0.9 | -0.45 | Upgrade
|
| Interest & Investment Income | 0 | 0 | 0.02 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.18 | 0 | -0.01 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.05 | 1.28 | -1.61 | -0.32 | -0.65 | -0.05 | Upgrade
|
| EBT Excluding Unusual Items | -7.59 | -10.47 | -8.6 | -3.73 | -7.79 | -3.11 | Upgrade
|
| Merger & Restructuring Charges | - | - | -0.12 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 4.77 | 0.39 | - | - | - | - | Upgrade
|
| Legal Settlements | - | -0.13 | - | - | - | - | Upgrade
|
| Other Unusual Items | -1.73 | -2.14 | - | - | - | - | Upgrade
|
| Pretax Income | -4.55 | -12.35 | -8.72 | -3.73 | -7.79 | -3.11 | Upgrade
|
| Net Income | -4.55 | -12.35 | -8.72 | -3.73 | -7.79 | -3.11 | Upgrade
|
| Net Income to Common | -4.55 | -12.35 | -8.72 | -3.73 | -7.79 | -3.11 | Upgrade
|
| Shares Outstanding (Basic) | 531 | 365 | 94 | 35 | 25 | 23 | Upgrade
|
| Shares Outstanding (Diluted) | 531 | 365 | 94 | 35 | 25 | 23 | Upgrade
|
| Shares Change (YoY) | 74.44% | 290.50% | 164.41% | 41.61% | 10.69% | 12.62% | Upgrade
|
| EPS (Basic) | -0.01 | -0.03 | -0.09 | -0.11 | -0.31 | -0.14 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.03 | -0.09 | -0.11 | -0.31 | -0.14 | Upgrade
|
| Free Cash Flow | -4.31 | -6.17 | -3.73 | -3.82 | -1.12 | -1.59 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.02 | -0.04 | -0.11 | -0.04 | -0.07 | Upgrade
|
| Gross Margin | 23.11% | 30.99% | 25.48% | 35.35% | 39.09% | 60.33% | Upgrade
|
| Operating Margin | -326.54% | -364.45% | -365.50% | -424.43% | -878.59% | -1416.20% | Upgrade
|
| Profit Margin | -235.65% | -507.54% | -683.33% | -475.41% | -1097.73% | -1687.13% | Upgrade
|
| Free Cash Flow Margin | -222.96% | -253.73% | -292.39% | -486.41% | -157.97% | -860.37% | Upgrade
|
| EBITDA | -5.78 | -8.33 | -4.44 | -3.15 | -6.11 | -2.43 | Upgrade
|
| D&A For EBITDA | 0.53 | 0.54 | 0.22 | 0.18 | 0.13 | 0.18 | Upgrade
|
| EBIT | -6.31 | -8.87 | -4.66 | -3.33 | -6.23 | -2.61 | Upgrade
|
| Advertising Expenses | - | 0.13 | 0.2 | 0.02 | 0 | 0 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.